CD8A and graft versus host disease: However, AMG44 treatment ameliorated GVHD severity induced by PERK-deficient CD8+ T cells (Supplemental Figure 10, E and F), suggesting that PERK inhibition could suppress CD4 helper function or non-T cells such as APCs.